Peter Hammarsten

1.4k total citations
27 papers, 1.2k citations indexed

About

Peter Hammarsten is a scholar working on Pulmonary and Respiratory Medicine, Molecular Biology and Pharmacology. According to data from OpenAlex, Peter Hammarsten has authored 27 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Pulmonary and Respiratory Medicine, 10 papers in Molecular Biology and 5 papers in Pharmacology. Recurrent topics in Peter Hammarsten's work include Prostate Cancer Treatment and Research (16 papers), Cannabis and Cannabinoid Research (5 papers) and Prostate Cancer Diagnosis and Treatment (5 papers). Peter Hammarsten is often cited by papers focused on Prostate Cancer Treatment and Research (16 papers), Cannabis and Cannabinoid Research (5 papers) and Prostate Cancer Diagnosis and Treatment (5 papers). Peter Hammarsten collaborates with scholars based in Sweden, United States and Italy. Peter Hammarsten's co-authors include Anders Bergh, Pär Stattin, Lars Egevad, Torvald Granfors, Pernilla Wikström, Andreas Josefsson, Christina Hägglöf, Sofia Halin Bergström, Christopher J. Fowler and Stina Häggström Rudolfsson and has published in prestigious journals such as PLoS ONE, Cancer Research and Clinical Cancer Research.

In The Last Decade

Peter Hammarsten

27 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Peter Hammarsten Sweden	19	482	433	273	261	224	27	1.2k
Scott Wise United States	17	660 1.4×	179 0.4×	161 0.6×	293 1.1×	195 0.9×	43	1.2k
Akira Morimiya United States	11	628 1.3×	159 0.4×	343 1.3×	504 1.9×	97 0.4×	16	1.1k
Rachel Bikoff United States	5	865 1.8×	315 0.7×	334 1.2×	247 0.9×	166 0.7×	7	1.3k
Roberto Würth Italy	21	763 1.6×	167 0.4×	272 1.0×	527 2.0×	154 0.7×	37	1.4k
Minna M. Tanner Finland	10	1.5k 3.1×	209 0.5×	418 1.5×	626 2.4×	143 0.6×	17	2.3k
Subhamoy Dasgupta United States	20	763 1.6×	200 0.5×	450 1.6×	276 1.1×	136 0.6×	33	1.2k
Mingzhi Han China	21	795 1.6×	258 0.6×	429 1.6×	215 0.8×	154 0.7×	39	1.2k
Annika Wulf-Goldenberg Germany	16	779 1.6×	112 0.3×	297 1.1×	352 1.3×	89 0.4×	27	1.2k
Chirayu Goswami United States	25	1.1k 2.3×	235 0.5×	572 2.1×	443 1.7×	161 0.7×	44	1.8k
Hema Parmar United States	13	656 1.4×	211 0.5×	198 0.7×	591 2.3×	172 0.8×	23	1.4k

Countries citing papers authored by Peter Hammarsten

Since Specialization

Citations

This map shows the geographic impact of Peter Hammarsten's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter Hammarsten with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter Hammarsten more than expected).

Fields of papers citing papers by Peter Hammarsten

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peter Hammarsten. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter Hammarsten. The network helps show where Peter Hammarsten may publish in the future.

Co-authorship network of co-authors of Peter Hammarsten

This figure shows the co-authorship network connecting the top 25 collaborators of Peter Hammarsten. A scholar is included among the top collaborators of Peter Hammarsten based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Peter Hammarsten. Peter Hammarsten is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Hammarsten, Peter, Christina Hägglöf, Pernilla Wikström, et al.. (2016). High Caveolin-1 Expression in Tumor Stroma Is Associated with a Favourable Outcome in Prostate Cancer Patients Managed by Watchful Waiting. PLoS ONE. 11(10). e0164016–e0164016. 20 indexed citations

Water, Thomas R. Van De, et al.. (2015). Morphological and morphometric characterization of direct transdifferentiation of support cells into hair cells in ototoxin-exposed neonatal utricular explants. Hearing Research. 321. 1–11. 4 indexed citations

Nilsson, Maria, Christina Hägglöf, Peter Hammarsten, et al.. (2015). High Lysyl Oxidase (LOX) in the Non-Malignant Prostate Epithelium Predicts a Poor Outcome in Prostate Cancer Patient Managed by Watchful Waiting. PLoS ONE. 10(10). e0140985–e0140985. 15 indexed citations

Bruzzese, Francesca, Christina Hägglöf, Alessandra Leone, et al.. (2014). Local and Systemic Protumorigenic Effects of Cancer-Associated Fibroblast-Derived GDF15. Cancer Research. 74(13). 3408–3417. 107 indexed citations

Häggström, Jenny, Mariateresa Cipriano, Emma Persson, et al.. (2014). Potential upstream regulators of cannabinoid receptor 1 signaling in prostate cancer: A Bayesian network analysis of data from a tissue microarray. The Prostate. 74(11). 1107–1117. 7 indexed citations

Hammarsten, Peter, Lars Egevad, Torvald Granfors, et al.. (2014). High density of S100A9 positive inflammatory cells in prostate cancer stroma is associated with poor outcome. European Journal of Cancer. 50(10). 1829–1835. 37 indexed citations

Hägglöf, Christina, Peter Hammarsten, Lars Egevad, et al.. (2014). TMPRSS2-ERG Expression Predicts Prostate Cancer Survival and Associates with Stromal Biomarkers. PLoS ONE. 9(2). e86824–e86824. 96 indexed citations

Hammarsten, Peter, Stina Häggström Rudolfsson, Jenny Häggström, et al.. (2014). ErbB2 Receptor Immunoreactivity in Prostate Cancer: Relationship to the Androgen Receptor, Disease Severity at Diagnosis and Disease Outcome. PLoS ONE. 9(9). e105063–e105063. 2 indexed citations

Cipriano, Mariateresa, Jenny Häggström, Peter Hammarsten, & Christopher J. Fowler. (2013). Association between Cannabinoid CB1 Receptor Expression and Akt Signalling in Prostate Cancer. PLoS ONE. 8(6). e65798–e65798. 20 indexed citations

10.

Fowler, Christopher J., Andreas Josefsson, Lina Thors, et al.. (2012). Tumour epithelial expression levels of endocannabinoid markers modulate the value of endoglin-positive vascular density as a prognostic marker in prostate cancer. Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids. 1831(10). 1579–1587. 4 indexed citations

11.

Josefsson, Andreas, Peter Hammarsten, Torvald Granfors, et al.. (2011). Prostate Cancer Increases Hyaluronan in Surrounding Nonmalignant Stroma, and This Response Is Associated with Tumor Growth and an Unfavorable Outcome. American Journal Of Pathology. 179(4). 1961–1968. 78 indexed citations

12.

Hammarsten, Peter, Andreas Josefsson, Stina Häggström Rudolfsson, et al.. (2010). Low Levels of Phosphorylated Epidermal Growth Factor Receptor in Nonmalignant and Malignant Prostate Tissue Predict Favorable Outcome in Prostate Cancer Patients. Clinical Cancer Research. 16(4). 1245–1255. 49 indexed citations

13.

Hägglöf, Christina, Peter Hammarsten, Andreas Josefsson, et al.. (2010). Stromal PDGFRβ Expression in Prostate Tumors and Non-Malignant Prostate Tissue Predicts Prostate Cancer Survival. PLoS ONE. 5(5). e10747–e10747. 91 indexed citations

14.

Thors, Lina, Anders Bergh, Emma Persson, et al.. (2010). Fatty Acid Amide Hydrolase in Prostate Cancer: Association with Disease Severity and Outcome, CB1 Receptor Expression and Regulation by IL-4. PLoS ONE. 5(8). e12275–e12275. 62 indexed citations

15.

Bergström, Sofia Halin, et al.. (2010). Tumor indicating normal tissue could be a new source of diagnostic and prognostic markers for prostate cancer. Expert Opinion on Medical Diagnostics. 5(1). 37–47. 34 indexed citations

16.

Wang, Baofeng, Peter Hammarsten, Anna Dahlman, et al.. (2010). LRIG1 and the liar paradox in prostate cancer: A study of the expression and clinical significance of LRIG1 in prostate cancer. International Journal of Cancer. 128(12). 2843–2852. 34 indexed citations

17.

Johansson, Anna, Stina Häggström Rudolfsson, Peter Hammarsten, et al.. (2010). Mast Cells Are Novel Independent Prognostic Markers in Prostate Cancer and Represent a Target for Therapy. American Journal Of Pathology. 177(2). 1031–1041. 168 indexed citations

18.

Hammarsten, Peter, Stina Häggström Rudolfsson, Roger Henriksson, Pernilla Wikström, & Anders Bergh. (2007). Inhibition of the epidermal growth factor receptor enhances castration‐induced prostate involution and reduces testosterone‐stimulated prostate growth in adult rats. The Prostate. 67(6). 573–581. 17 indexed citations

19.

Bergström, Sofia Halin, Peter Hammarsten, Pernilla Wikström, & Anders Bergh. (2006). Androgen‐insensitive prostate cancer cells transiently respond to castration treatment when growing in an androgen‐dependent prostate environment. The Prostate. 67(4). 370–377. 55 indexed citations

20.

Lissbrant, Ingela Franck, Peter Hammarsten, Erik Lissbrant, et al.. (2003). Neutralizing VEGF bioactivity with a soluble chimeric VEGF‐receptor protein flt(1‐3)IgG inhibits testosterone‐stimulated prostate growth in castrated mice. The Prostate. 58(1). 57–65. 42 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact